Influenza and SARS-CoV-2 Detection by RT-PCR, Molecular

Influenza and SARS-CoV-2 Detection by RT-PCR, Molecular

Test Name: FluV19 Testing by Real-Time RT-PCR
Method Name: Real Time Reverse Transcriptase – Polymerase Chain Reaction (PCR) for Influenza A, Influenza B, and SARS-CoV-2.
Results: Detected, Not Detected, Inconclusive
Reference Ranges: Not Detected for all targets on panel
Clinical Significance: Viral transmission is person to person through direct contact with upper respiratory droplets containing virus from symptomatic and asymptomatic carriers. Symptoms range from mild to severe including severe acute respiratory distress (ARDS) with fever, cough, and shortness of breath. Some patients have also demonstrated sore throat and gastrointestinal distress and/or renal failure.
Submission Criteria: Specimen types include nasopharyngeal swabs and nasal swabs collected in a minimum of 1 ml of Viral Transport Media (VTM), Universal Transport Media (UTM), Sterile Saline, or ESwab.
Rejection criteria include but are not limited to those with: Rejection criteria include but are not limited to:
1. Mismatched requisitions.
2. Specimens without patient identifiers
3. Specimens stored or shipped incorrectly
4. Specimens collected using expired reagents
5. Specimens submitted without approval
Authorization: Diagnostic testing can only be performed with approval from an authorized provider/agency.
Turn Around Time: 3 Days